Total number of shares and voting rights in Zealand Pharma on August 30, 2024
30 August 2024 - 5:00PM
UK Regulatory
Total number of shares and voting rights in Zealand Pharma on
August 30, 2024
Company announcement – No. 42 / 2024
Total number of shares and voting rights in Zealand Pharma on
August 30, 2024
Copenhagen, Denmark, August 30, 2024 –
Zealand Pharma A/S (“Zealand”) (NASDAQ: ZEAL) (CVR-no. 20 04 50
78), a Copenhagen-based biotechnology company focused on the
discovery and development of innovative peptide-based medicines, in
accordance with section 32 of the Danish Capital Markets Act,
announces the total number of shares and voting rights in the
Company at the end of a calendar month during which there have been
changes to its share capital.
In Company announcement No. 41/2024 from August 22, 2024,
Zealand announced an increase in share capital relating to exercise
of employee warrants. Following this announcement, the table below
lists the total number of shares and voting rights in Zealand up to
and including August 30, 2024.
Date |
Number of shares
(nominal value of DKK 1 each) |
Share capital
(nominal value in DKK) |
Number of voting rights |
August 30, 2024 |
71,013,761 |
71,013,761 |
71,013,761 |
# # #
About Zealand Pharma A/S
Zealand Pharma A/S (Nasdaq: ZEAL) ("Zealand") is a biotechnology
company focused on the discovery and development of peptide-based
medicines. More than 10 drug candidates invented by Zealand have
advanced into clinical development, of which two have reached the
market and three candidates are in late-stage development. The
company has development partnerships with a number of blue-chip
pharma companies as well as commercial partnerships for its
marketed products.
Zealand was founded in 1998 and is headquartered in Copenhagen,
Denmark, with a presence in the U.S. For more information about
Zealand’s business and activities, please
visit www.zealandpharma.com.
Contact:
|
Adam Lange
Investor Relations Officer
Zealand Pharma
Email: akl@zealandpharma.com |
|
Anna Krassowska, PhD
Vice President, Investor Relations & Corporate
Communications
Zealand Pharma
Email: ank@zealandpharma.com |
Zealand Pharma AS (TG:22Z)
Historical Stock Chart
Von Okt 2024 bis Nov 2024
Zealand Pharma AS (TG:22Z)
Historical Stock Chart
Von Nov 2023 bis Nov 2024